Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Grade Honey for CIN II
NCT06219018Phase 2Recruiting
- Sponsor
- Zuyderland
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of Revamil in cervical intraepithelial neoplasia (CIN), human papillomavirus infection, sponsored by Zuyderland. Started Dec 2024; status: recruiting.
02
Drugs
Revamil
03
Conditions
cervical intraepithelial neoplasia (CIN)human papillomavirus infection
Beyond the preview
Go deeper on NCT06219018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06219018.